Tesamorelin Dosage for Fat Loss: What Does the Research Studies Actually Say?
Let’s talk about something that’s been gaining a lot of traction in the biohacking and TRT communities lately: Tesamorelin. If you’ve been paying attention to the peptide space, you’ve probably seen Tesamorelin being hyped as the secret weapon for stubborn belly fat. You know the kind I’m talking about—that visceral fat that doesn’t budge no matter how clean you eat or how much cardio you do. The fat that seems to stick around even when your testosterone levels are dialed in and your diet is on point. I’ve been digging into the research on this compound for a while now, and I wanted to put together a post that actually answers the question everyone keeps asking: what’s the real Tesamorelin dosage for fat loss based on actual studies, not just bro-science? Because there’s a lot of noise out there, and when you’re injecting something into your body, you want to get this right. What Exactly Is Tesamorelin? Before we get into dosing, let’s make sure we understand what Tesamorelin is and why it works the way it does. Tesamorelin is a growth hormone-releasing hormone (GHRH) analog. In simple terms, it’s a synthetic peptide that stimulates your pituitary gland to release more of your own growth hormone in a pulsatile manner. Unlike synthetic HGH, which floods your system all at once and can cause side effects like joint pain, carpal tunnel, and insulin resistance, Tesamorelin works with your body’s natural rhythms. Here’s an analogy I like: think of your natural growth hormone production like a fireplace. Synthetic HGH is like dumping a whole can of lighter fluid on it—big flame, lots of smoke, but it burns out fast and can leave a mess. Tesamorelin is like adding good, seasoned hardwood. It keeps the fire burning steadily, with clean heat, in a way that your body already knows how to manage. What makes Tesamorelin unique is that it’s actually FDA-approved for a specific condition: HIV-associated lipodystrophy, which causes excessive accumulation of visceral abdominal fat. The clinical trials for that indication showed something remarkable—not only did Tesamorelin reduce visceral fat, but it did so without significant loss of subcutaneous fat or lean mass.